Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paediatric use of second-line anti-tuberculosis agents: a review.
Seddon JA, Hesseling AC, Marais BJ, McIlleron H, Peloquin CA, Donald PR, Schaaf HS. Seddon JA, et al. Among authors: mcilleron h. Tuberculosis (Edinb). 2012 Jan;92(1):9-17. doi: 10.1016/j.tube.2011.11.001. Epub 2011 Nov 25. Tuberculosis (Edinb). 2012. PMID: 22118883 Review.
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.
Sirgel FA, Fourie PB, Donald PR, Padayatchi N, Rustomjee R, Levin J, Roscigno G, Norman J, McIlleron H, Mitchison DA. Sirgel FA, et al. Among authors: mcilleron h. Am J Respir Crit Care Med. 2005 Jul 1;172(1):128-35. doi: 10.1164/rccm.200411-1557OC. Epub 2005 Apr 1. Am J Respir Crit Care Med. 2005. PMID: 15805182 Clinical Trial.
Requirements for the clinical evaluation of new anti-tuberculosis agents in children.
Donald PR, Ahmed A, Burman WJ, Cotton MF, Graham SM, Mendel C, McIlleron H, Mac Kenzie WR, Nachman S, Schaaf HS, Starke JR, Wingfield C, Hesseling AC. Donald PR, et al. Among authors: mcilleron h. Int J Tuberc Lung Dis. 2013 Jun;17(6):794-9. doi: 10.5588/ijtld.12.0567. Int J Tuberc Lung Dis. 2013. PMID: 23676164
Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses.
Zvada SP, Denti P, Donald PR, Schaaf HS, Thee S, Seddon JA, Seifart HI, Smith PJ, McIlleron HM, Simonsson US. Zvada SP, et al. Among authors: mcilleron hm. J Antimicrob Chemother. 2014 May;69(5):1339-49. doi: 10.1093/jac/dkt524. Epub 2014 Jan 31. J Antimicrob Chemother. 2014. PMID: 24486870 Free PMC article.
Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.
Thee S, Garcia-Prats AJ, McIlleron HM, Wiesner L, Castel S, Norman J, Draper HR, van der Merwe PL, Hesseling AC, Schaaf HS. Thee S, et al. Among authors: mcilleron hm. Antimicrob Agents Chemother. 2014 May;58(5):2948-51. doi: 10.1128/AAC.02755-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550337 Free PMC article.
212 results